Terms: = Breast cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839
62 results:
1. Genomic transcription factor binding site selection is edited by the chromatin remodeling factor chd4.
Saotome M; Poduval DB; Grimm SA; Nagornyuk A; Gunarathna S; Shimbo T; Wade PA; Takaku M
Nucleic Acids Res; 2024 Apr; 52(7):3607-3622. PubMed ID: 38281186
[TBL] [Abstract] [Full Text] [Related]
2. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through chd4 degradation and Wnt/β-catenin pathway inhibition.
Xiao G; Lu W; Yuan J; Liu Z; Wang P; Fan H
J Transl Med; 2024 Jan; 22(1):99. PubMed ID: 38268032
[TBL] [Abstract] [Full Text] [Related]
3. Evidence of a synthetic lethality interaction between SETDB1 histone methyltransferase and chd4 chromatin remodeling protein in a triple negative breast cancer cell line.
Moraes-Almeida MS; Sogayar MC; Demasi MAA
Braz J Med Biol Res; 2023; 56():e12854. PubMed ID: 37970920
[TBL] [Abstract] [Full Text] [Related]
4. Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With breast cancer.
Lee JE; Kwon SH; Kwon S; Jung HI; Nam JH; Lee EK
JAMA Netw Open; 2023 Jul; 6(7):e2324852. PubMed ID: 37477917
[TBL] [Abstract] [Full Text] [Related]
5. Role of duct excision surgery in the treatment of pathological nipple discharge and detection of breast carcinoma: systematic review.
Makineli S; van Wijnbergen JWM; Vriens MR; van Diest PJ; Witkamp AJ
BJS Open; 2023 Jul; 7(4):. PubMed ID: 37459137
[TBL] [Abstract] [Full Text] [Related]
6. chd4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma.
Chang SJ; Bin PJ; Luo CW; Chai CY
Pathol Res Pract; 2022 Dec; 240():154173. PubMed ID: 36306724
[TBL] [Abstract] [Full Text] [Related]
7. Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review.
Palmisciano P; Chen AL; Sharma M; Bin-Alamer O; Ferini G; Umana GE; Aoun SG; Haider AS
Anticancer Res; 2022 Jul; 42(7):3251-3259. PubMed ID: 35790288
[TBL] [Abstract] [Full Text] [Related]
8. Practice patterns among oncologists participating in the oncology care model after three years.
Walker B; Wilfong L; Frytak J; Robert N
J Cancer Policy; 2021 Sep; 29():100294. PubMed ID: 35559949
[TBL] [Abstract] [Full Text] [Related]
9. Evaluating educational interventions to increase breast density awareness among Latinas: A randomized trial in a Federally Qualified Health Center.
Ridgeway JL; Jenkins SM; Borah BJ; Suman VJ; Patel BK; Ghosh K; Rhodes DJ; Norman A; Ramos EP; Jewett M; Gonzalez CR; Hernandez V; Singh D; Sosa M; Radecki Breitkopf C; Vachon CM
Cancer; 2022 Mar; 128(5):1038-1047. PubMed ID: 34855208
[TBL] [Abstract] [Full Text] [Related]
10. chd4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
Chang CL; Huang CR; Chang SJ; Wu CC; Chen HH; Luo CW; Yip HK
Int J Biol Sci; 2021; 17(7):1660-1670. PubMed ID: 33994851
[TBL] [Abstract] [Full Text] [Related]
11. Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers.
Aimi F; Moch H; Schraml P; Hottiger MO
Mod Pathol; 2021 Aug; 34(8):1468-1477. PubMed ID: 33742140
[TBL] [Abstract] [Full Text] [Related]
12. Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation.
Coassolo S; Davidson G; Negroni L; Gambi G; Daujat S; Romier C; Davidson I
Nat Commun; 2021 Mar; 12(1):1718. PubMed ID: 33741961
[TBL] [Abstract] [Full Text] [Related]
13. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/chd4 Axis in breast cancer.
Hao J; Du X; Lv F; Shi Q
J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
[TBL] [Abstract] [Full Text] [Related]
14. Phased-array combination of 2D MRS for lipid composition quantification in patients with breast cancer.
Mallikourti V; Cheung SM; Gagliardi T; Senn N; Masannat Y; McGoldrick T; Sharma R; Heys SD; He J
Sci Rep; 2020 Nov; 10(1):20041. PubMed ID: 33208767
[TBL] [Abstract] [Full Text] [Related]
15. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract] [Full Text] [Related]
16. chd4 Promotes breast cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
Wang Y; Chen Y; Bao L; Zhang B; Wang JE; Kumar A; Xing C; Wang Y; Luo W
Cancer Res; 2020 Sep; 80(18):3880-3891. PubMed ID: 32699137
[TBL] [Abstract] [Full Text] [Related]
17. Young onset breast cancer in Southern China - a 5-year clinico-pathological study from a multi-centre database.
Co M; Kwong A
Cancer Treat Res Commun; 2020; 24():100182. PubMed ID: 32534410
[TBL] [Abstract] [Full Text] [Related]
18. Correlation Between Electrophysiological Changes and Outcomes of Vocal Cord Function in 1764 Recurrent Laryngeal Nerves with Visual Integrity During Thyroidectomy.
Yuan Q; Wu G; Hou J; Liao X; Liao Y; Chiang FY
Thyroid; 2020 May; 30(5):739-745. PubMed ID: 31880997
[No Abstract] [Full Text] [Related]
19. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.
Ho AY; Barker CA; Arnold BB; Powell SN; Hu ZI; Gucalp A; Lebron-Zapata L; Wen HY; Kallman C; D'Agnolo A; Zhang Z; Flynn J; Dunn SA; McArthur HL
Cancer; 2020 Feb; 126(4):850-860. PubMed ID: 31747077
[TBL] [Abstract] [Full Text] [Related]
20. Identification of chd4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
[TBL] [Abstract] [Full Text] [Related]
[Next]
